Search research articles
Contact Us
Filters
Showing results (101-110 of 174) with videos related to
Page
of 18
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
November 13, 2021
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial
Alexander Rühle, Nicole Wiedenmann, Jamina T Fennell, et al.
Theranostics
|
March 1, 2014
Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to men
Gesche Wieser, Rosalba Mansi, Anca L Grosu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2025
Biologically Individualized Radiotherapy Based on PET: A Novel Approach to Treatment Optimization of Head and Neck Cancer
Marta Lazzeroni, Ana Ureba, Henning Schäfer, et al.
Radiation Oncology (London, England)
|
July 24, 2013
3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study
Hans Christian Rischke, Ursula Nestle, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 29, 2020
Intraindividual comparison between <sup>68</sup>Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
Simon Spohn, Chiara Jaegle, Thomas F Fassbender, et al.
Radiation Oncology (London, England)
|
August 13, 2014
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer
Cordula A Jilg, Anja Leifert, Daniel Schnell, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 27, 2020
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Matthias Guckenberger, Wolfgang W Baus, Oliver Blanck, et al.
NPJ Precision Oncology
|
March 2, 2023
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Eleni Gkika, Elke Firat, Sonja Adebahr, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 14, 2017
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference
Constantinos Zamboglou, Ilias Sachpazidis, Khodor Koubar, et al.
Theranostics
|
August 2, 2021
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies
Simon K B Spohn, Alisa S Bettermann, Fabian Bamberg, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 174) with videos related to
Sort By:
Page
of 18
European Journal of Nuclear Medicine and Molecular Imaging
|
November 13, 2021
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial
Alexander Rühle, Nicole Wiedenmann, Jamina T Fennell, et al.
Theranostics
|
March 1, 2014
Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to men
Gesche Wieser, Rosalba Mansi, Anca L Grosu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2025
Biologically Individualized Radiotherapy Based on PET: A Novel Approach to Treatment Optimization of Head and Neck Cancer
Marta Lazzeroni, Ana Ureba, Henning Schäfer, et al.
Radiation Oncology (London, England)
|
July 24, 2013
3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study
Hans Christian Rischke, Ursula Nestle, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 29, 2020
Intraindividual comparison between <sup>68</sup>Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients
Simon Spohn, Chiara Jaegle, Thomas F Fassbender, et al.
Radiation Oncology (London, England)
|
August 13, 2014
Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer
Cordula A Jilg, Anja Leifert, Daniel Schnell, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 27, 2020
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
Matthias Guckenberger, Wolfgang W Baus, Oliver Blanck, et al.
NPJ Precision Oncology
|
March 2, 2023
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Eleni Gkika, Elke Firat, Sonja Adebahr, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 14, 2017
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using <sup>68</sup>Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference
Constantinos Zamboglou, Ilias Sachpazidis, Khodor Koubar, et al.
Theranostics
|
August 2, 2021
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies
Simon K B Spohn, Alisa S Bettermann, Fabian Bamberg, et al.
Page
of 18